Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-035869
Filing Date
2012-06-11
Accepted
2012-06-11 18:25:18
Documents
1
Period of Report
2012-06-07

Document Format Files

Seq Description Document Type Size
1 MAHAFFY ANNUAL GRANT rrd348436.html 4  
1 MAHAFFY ANNUAL GRANT rrd348436.xml 4 4336
  Complete submission text file 0001181431-12-035869.txt   5731
Mailing Address C/O PHARMION CORP 2525 28TH ST BOULDER CO 80301
Business Address
MAHAFFY PATRICK J (Reporting) CIK: 0001266569 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33415 | Film No.: 12901608

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations